Evidence map›Paper›PMID 31555959›Full record

ArticleClinical journal of gastroenterology2020

Ten-year follow-up study of linear immunoglobulin A dermatosis complicated with ulcerative colitis.

Hiroki Sonoyama, Yoshiyuki Mishima, Shunji Ishihara, Naoki Oshima, Ichiro Moriyama, Kousaku Kawashima, Yuko Chinuki, Eishin Morita, Yoshikazu Kinoshita

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Clinical journal of gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Hiroki SonoyamaDepartment of Internal Medicine II, Faculty of Medicine, Shimane University, Izumo, Japan.
Yoshiyuki MishimaDepartment of Internal Medicine II, Faculty of Medicine, Shimane University, Izumo, Japan.
Shunji IshiharaDepartment of Internal Medicine II, Faculty of Medicine, Shimane University, Izumo, Japan. si360405@med.shimane-u.ac.jp.
Naoki OshimaDepartment of Internal Medicine II, Faculty of Medicine, Shimane University, Izumo, Japan.
Ichiro MoriyamaDepartment of Internal Medicine II, Faculty of Medicine, Shimane University, Izumo, Japan.
Kousaku KawashimaDepartment of Internal Medicine II, Faculty of Medicine, Shimane University, Izumo, Japan.
Yuko ChinukiDepartment of Internal Medicine II, Faculty of Medicine, Shimane University, Izumo, Japan.
Eishin MoritaDepartment of Internal Medicine II, Faculty of Medicine, Shimane University, Izumo, Japan.
Yoshikazu KinoshitaDepartment of Internal Medicine II, Faculty of Medicine, Shimane University, Izumo, Japan.
Shimane University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Linear immunoglobulin A dermatosis (LAD) is rarely complicated in patients with ulcerative colitis (UC), though the long-term prognosis in those with concurrent LAD and UC is not fully understood. Here, we report findings obtained in follow-up examinations performed over a 10-year period of a UC patient initially complicated with LAD. We treated an 18-year-old male for relapse of UC with deteriorating blisters diagnosed as LAD. Following successful induction therapy for both UC and LAD with oral prednisolone, the patient was followed for 10 years. Skin condition remained good at each examination, even with second and third relapses of UC. Our findings in this case indicate that LAD is rarely complicated with UC, while it has no association with colitis disease activity. Furthermore, adequate treatment following an initial diagnosis of LAD is important for management of affected UC patients.

Indexed as

AdolescentAnti-Inflammatory AgentsColitis, UlcerativeFollow-Up StudiesHumansLinear IgA Bullous DermatosisMalePrednisoloneTime FactorsAnti-Inflammatory AgentsPrednisoloneIBDIgAInflammatory bowel disease + blister

Identifiers

PMID31555959
OpenAlexW2976274464

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.